DUBLIN–(BUSINESS WIRE)–The “AI-based Digital Pathology Market: Industry Trends and Global Forecasts, Till 2035 – Distribution by Type of Neural Network, Type ofDUBLIN–(BUSINESS WIRE)–The “AI-based Digital Pathology Market: Industry Trends and Global Forecasts, Till 2035 – Distribution by Type of Neural Network, Type of

AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “AI-based Digital Pathology Market: Industry Trends and Global Forecasts, Till 2035 – Distribution by Type of Neural Network, Type of Assay, Type of End-User, Area of Application, Target Disease Indication and Key Geographies” has been added to ResearchAndMarkets.com’s offering.

The global AI-based digital pathology market is projected to expand from USD 1.01 billion in the current year to USD 2.32 billion by 2035, reflecting a CAGR of 8.7%. This growth is driven by technological advancements and an emphasis on precision medicine that have enhanced digital pathology techniques, allowing for more efficient quantitative and qualitative assessments.

Market Dynamics and Opportunities

The adoption of AI in digital pathology has revolutionized slide examination, replacing traditional microscopy. Digitizing glass slides facilitates rapid transmission from diagnostic centers to pathologists, significantly improving tissue micro-environment comprehension. AI integration in diagnostics allows tailored treatment strategies and patient categorization, fostering a transformative care delivery model across pathology subdomains.

Market Insights

Currently, about 80 companies offer AI-based digital pathology services worldwide, primarily to research institutes and diagnostic facilities. Companies provide a range of AI-based solutions, enhanced through proprietary products chiefly employed in research and diagnostics.

The market has attracted substantial investment, with approximately USD 2 billion invested over 60 funding events. Factors such as the integration of AI into clinical workflows and increased global adoption of these tools have propelled market growth, anticipated to maintain an 8.70% annualized rate till 2035.

Key Insights:

  • The demand for AI-based digital pathology solutions is growing, with convolutional neural networks leading the market due to their extensive application range. Ki67 assays dominate the market due to high relevance in cell proliferation.
  • Research institutes currently hold the largest market share, with diagnostic applications predicted to show higher growth rates. Breast cancer is the primary disease indication, capturing the largest market share.
  • Geographically, North America holds the most significant market share, while Europe’s market is expected to grow at a higher CAGR.

Featured Players:

  • Aiforia Technologies
  • Akoya Biosciences
  • Ibex Medical Analytics
  • Indica Labs
  • Paige
  • PathAI
  • PROSCIA
  • Roche Tissue Diagnostics
  • Visiopharm

Research and Analysis

The report includes extensive market sizing and opportunity analysis, segmentation by neural network type, assay, end-user, and target disease indication. It also provides a thorough company landscape evaluation and competitiveness analysis, focusing on market leaders and emerging players.

Reasons to Buy:

  • Comprehensive market analysis with detailed revenue projections and insights into competitive dynamics for strategic decision-making.
  • Access to key market trends and growth prospects, empowering stakeholders to capitalize on emerging opportunities.

Additional Benefits:

  • Complimentary PPT Insights Packs and Excel Data Packs
  • Free content customization and report updates
  • Detailed walkthrough sessions with the research team

Key Attributes

Report AttributeDetails
No. of Pages212
Forecast Period2025-2035
Estimated Market Value (USD) in 2025$1.01 Billion
Forecasted Market Value (USD) by 2035$2.32 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal

Key Topics Covered

1. PREFACE

  • 1.1. Chapter Overview
  • 1.2. Market Segmentations
  • 1.3. Research Methodology
  • 1.4. Key Questions Answered
  • 1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Artificial Intelligence in Digital Pathology
  • 3.3. Workflow of AI-based Digital Pathology
  • 3.4. Applications of AI-based Digital Pathology Solutions
  • 3.5. Regulatory Requirements Focused on AI-based Digital Pathology
  • 3.6. Challenges Associated with the Use of AI in Digital Pathology
  • 3.7. Future Perspectives

4. AI-BASED DIGITAL PATHOLOGY: MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. AI-based Digital Pathology Providers: Developers Landscape
  • 4.3. AI-based Digital Pathology Providers: Market Landscape

5. AI-BASED DIGITAL PATHOLOGY MARKET: KEY INSIGHTS

  • 5.1. Chapter Overview

6. COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. PathAI
  • 6.3. Paige
  • 6.4. Akoya Biosciences
  • 6.5. PROSCIA
  • 6.6. Visiopharm
  • 6.7. Roche Tissue Diagnostics
  • 6.8. Aiforia Technologies
  • 6.9. Indica Labs
  • 6.10. Ibex Medical Analytics

7. COMPANY COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Assumptions and Key Parameters
  • 7.3. Methodology

8. FUNDING AND INVESTMENTS

  • 8.1. Chapter Overview
  • 8.2. Types of Funding

9. DEMAND ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology

10. MARKET SIZING AND OPPORTUNITY ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Forecast Methodology and Key Assumptions

11. CONCLUDING REMARKS

12. EXECUTIVE INSIGHTS

13. APPENDIX 1: TABULATED DATA

14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

A selection of companies mentioned in this report includes, but is not limited to:

  • 3D HISTECH
  • 50 Partners
  • 83North
  • 8VC
  • ACME Investments
  • Act Venture Capital
  • Adage
  • aetherAI
  • Agilent Technologies
  • Aiforia
  • Akoya Biosciences
  • Aktia Nordic Micro Cap
  • Alpha Intelligence Capital
  • Alverno Laboratories
  • aMoon
  • AnaPath
  • Angels Sante
  • APEX Ventures
  • Ascend Capital Partners
  • ATP
  • Augmentiqs
  • Augsburg University Hospital
  • Aventior
  • Axon Diagnostics
  • BankInvest
  • Bayern Kapital
  • BGV
  • Biospring Partners
  • BioView
  • Blue Venture Fund
  • Breyer Capital
  • Bristol Myers Squibb
  • and many more!

For more information about this report visit https://www.researchandmarkets.com/r/g1fqw

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Fed rate decision September 2025

Fed rate decision September 2025

The post Fed rate decision September 2025 appeared on BitcoinEthereumNews.com. WASHINGTON – The Federal Reserve on Wednesday approved a widely anticipated rate cut and signaled that two more are on the way before the end of the year as concerns intensified over the U.S. labor market. In an 11-to-1 vote signaling less dissent than Wall Street had anticipated, the Federal Open Market Committee lowered its benchmark overnight lending rate by a quarter percentage point. The decision puts the overnight funds rate in a range between 4.00%-4.25%. Newly-installed Governor Stephen Miran was the only policymaker voting against the quarter-point move, instead advocating for a half-point cut. Governors Michelle Bowman and Christopher Waller, looked at for possible additional dissents, both voted for the 25-basis point reduction. All were appointed by President Donald Trump, who has badgered the Fed all summer to cut not merely in its traditional quarter-point moves but to lower the fed funds rate quickly and aggressively. In the post-meeting statement, the committee again characterized economic activity as having “moderated” but added language saying that “job gains have slowed” and noted that inflation “has moved up and remains somewhat elevated.” Lower job growth and higher inflation are in conflict with the Fed’s twin goals of stable prices and full employment.  “Uncertainty about the economic outlook remains elevated” the Fed statement said. “The Committee is attentive to the risks to both sides of its dual mandate and judges that downside risks to employment have risen.” Markets showed mixed reaction to the developments, with the Dow Jones Industrial Average up more than 300 points but the S&P 500 and Nasdaq Composite posting losses. Treasury yields were modestly lower. At his post-meeting news conference, Fed Chair Jerome Powell echoed the concerns about the labor market. “The marked slowing in both the supply of and demand for workers is unusual in this less dynamic…
Share
BitcoinEthereumNews2025/09/18 02:44
GBP/USD rallies as Fed independence threats hammer US Dollar

GBP/USD rallies as Fed independence threats hammer US Dollar

The post GBP/USD rallies as Fed independence threats hammer US Dollar appeared on BitcoinEthereumNews.com. The British Pound (GBP) extends its gains on Wednesday
Share
BitcoinEthereumNews2026/01/15 00:19
Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be

Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be

The post Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be appeared on BitcoinEthereumNews.com. Jordan Love and the Green Bay Packers are off to a 2-0 start. Getty Images The Green Bay Packers are, once again, one of the NFL’s better teams. The Cleveland Browns are, once again, one of the league’s doormats. It’s why unbeaten Green Bay (2-0) is a 8-point favorite at winless Cleveland (0-2) Sunday according to betmgm.com. The money line is also Green Bay -500. Most expect this to be a Packers’ rout, and it very well could be. But Green Bay knows taking anyone in this league for granted can prove costly. “I think if you look at their roster, the paper, who they have on that team, what they can do, they got a lot of talent and things can turn around quickly for them,” Packers safety Xavier McKinney said. “We just got to kind of keep that in mind and know we not just walking into something and they just going to lay down. That’s not what they going to do.” The Browns certainly haven’t laid down on defense. Far from. Cleveland is allowing an NFL-best 191.5 yards per game. The Browns gave up 141 yards to Cincinnati in Week 1, including just seven in the second half, but still lost, 17-16. Cleveland has given up an NFL-best 45.5 rushing yards per game and just 2.1 rushing yards per attempt. “The biggest thing is our defensive line is much, much improved over last year and I think we’ve got back to our personality,” defensive coordinator Jim Schwartz said recently. “When we play our best, our D-line leads us there as our engine.” The Browns rank third in the league in passing defense, allowing just 146.0 yards per game. Cleveland has also gone 30 straight games without allowing a 300-yard passer, the longest active streak in the NFL.…
Share
BitcoinEthereumNews2025/09/18 00:41